These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15032731)

  • 1. Challenges in antimicrobial drug discovery and the potential of nucleoside antibiotics.
    Rachakonda S; Cartee L
    Curr Med Chem; 2004 Mar; 11(6):775-93. PubMed ID: 15032731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia.
    Gebre-Sealsssie S
    Ethiop Med J; 2007 Oct; 45(4):363-70. PubMed ID: 18326346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future challenges in the development of antimicrobial agents.
    Rennie RP
    Handb Exp Pharmacol; 2012; (211):45-65. PubMed ID: 23090595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering nucleoside antibiotics toward the development of novel antimicrobial agents.
    Niu G; Li Z; Huang P; Tan H
    J Antibiot (Tokyo); 2019 Dec; 72(12):906-912. PubMed ID: 31501499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?
    Serpi M; Ferrari V; Pertusati F
    J Med Chem; 2016 Dec; 59(23):10343-10382. PubMed ID: 27607900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial drug resistance in Latin America: consequences for infectious disease control].
    Casellas JM
    Rev Panam Salud Publica; 2011 Dec; 30(6):519-28. PubMed ID: 22358396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets and screening approaches in antimicrobial drug discovery.
    Brown ED; Wright GD
    Chem Rev; 2005 Feb; 105(2):759-74. PubMed ID: 15700964
    [No Abstract]   [Full Text] [Related]  

  • 10. Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of theophylline containing acetylenes and theophylline containing 1,2,3-triazoles with variant nucleoside derivatives.
    Ruddarraju RR; Murugulla AC; Kotla R; Chandra Babu Tirumalasetty M; Wudayagiri R; Donthabakthuni S; Maroju R; Baburao K; Parasa LS
    Eur J Med Chem; 2016 Nov; 123():379-396. PubMed ID: 27487568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
    Cunha BA
    Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bloodstream infections in southwestern China: 2012 Whire Union report on bacterial susceptibility to antibiotics].
    Huang YC; Xie Y; Chen ZX; Liu B; Fei Y; Du Y; Shan B; Kang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 46(1):75-81. PubMed ID: 25993745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2004 May; 49(1):63-5. PubMed ID: 15135503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reflection on bacterial resistance to antimicrobial agents at a major tertiary care center in Lebanon over a decade.
    Araj GF; Avedissian AZ; Ayyash NS; Bey HA; El Asmar RG; Hammoud RZ; Itani LY; Malak MR; Sabai SA
    J Med Liban; 2012; 60(3):125-35. PubMed ID: 23198452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of macrocyclic nucleoside antibacterials and their interactions with MraY.
    Nakaya T; Yabe M; Mashalidis EH; Sato T; Yamamoto K; Hikiji Y; Katsuyama A; Shinohara M; Minato Y; Takahashi S; Horiuchi M; Yokota SI; Lee SY; Ichikawa S
    Nat Commun; 2022 Dec; 13(1):7575. PubMed ID: 36539416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleosides 9: Design and synthesis of new 8-nitro and 8-amino xanthine nucleosides of expected biological activity.
    Mohamed MANM; Abu-Alola LMB; Aljaied NMG
    Nucleosides Nucleotides Nucleic Acids; 2017 Dec; 36(12):745-756. PubMed ID: 29239699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization and high-throughput screening of antimicrobial peptides.
    Blondelle SE; Lohner K
    Curr Pharm Des; 2010; 16(28):3204-11. PubMed ID: 20687884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.